该网页正在调整中，因此，无法以您所使用的语言显示所有内容。
对于给您带来的不便，我们深表歉意。
基立福是一个全球性的医疗保健集团，于1909年在巴塞罗那成立，致力于改善全世界人民的健康和福祉。它的三个主要业务部门——生物制药、诊断和生物用品——开发、生产和销售的创新解决方案和服务在100多个国家销售。
基立福尊重将个人数据委托给基立福的所有数据主体的隐私权，并承诺遵守各国家/地区适用的数据保护法规。
本隐私声明根据欧盟通用数据保护条例（"GDPR"）第7节。它概述了基立福的数据收集做法以及数据主体对基立福收集、使用和分享其个人数据方式的选择。
本隐私声明适用于处理以下人员的个人数据：（a）属于基立福提供或可能提供服务和/或产品的机构的医疗保健专业人员、商业联系人和个人，以及（b）直接或间接与基立福合作或可能合作的医疗保健专业人员或商业联系人。在本隐私声明中，“数据主体”是指这两种类型的个人。
1，个人数据控制方/所有方的身份识别
数据控制方/所有方是：
当个人数据的处理具有科学目的时，个人数据控制方/所有方将共同为第1（a）、（b）或（c）节中确定的公司和Grifols,S.A.。
基立福集团公司的识别信息和联系方式可在此获得。作为控制方或联合控制方的基立福集团公司将被称为“基立福”。
2，明确数据保护专员
数据保护专员充当基立福与您之间的对话者，以确保基立福遵守数据保护法规，并保障您在此类法规下的权利。您可以通过dpo@grifols.com联络数据保护专员，除非数据控制者为Grifols Deutschland GmbH或Haema AG，对于这两家公司，您可以分别通过dsb@grifols.com 和dsb@haema.de联系其数据保护专员。
尽管本隐私声明提供了第1节所列出的联合控制协议的基本内容，但如果数据主体愿意，他们可以询问数据保护专员以了解更多信息。
3，目的、处理的合法依据、个人数据的类别和接收方
- To contact data subjects by any means, including electronic ones, to evaluate potential business opportunities and collaborations, and to develop, control and manage current and future relationships. 与数据主体联系的原因可能包括但不限于：
- Scheduling appointments (online or in-person),
- Evaluating their participation as speakers or members in advisory boards, symposiums, conferences, webinars, training sessions, scientific awards, clinical studies or similar events organized by Grifols or by third parties (online or in-person), and in drafting scientific publications,
- Sending surveys or similar, and
- Any other activities that may contribute to evaluating potential business opportunities.
- To assess and, if applicable, to respond to any requests for information or suggestions.
- To develop and maintain the relationship with personnel of the organizations with whom Grifols has a contractual relationship, including the management of training sessions.
个人数据类别：
接收者：
合法利益
- To send scientific, educational and commercial information about Grifols’ group products, services, and activities, by any means, including electronic ones, when there is a contractual relationship with the data subject (e.g. direct marketing).
- To send scientific and educational information, which is not related to Grifols’ group products, services and activities, to increase the knowledge in the scientific community.
个人数据类别：
接收者：
合法利益
- To carry out anticorruption compliance checks.
个人数据类别：
接收者：
合法利益
- To carry out maintenance tasks in websites, landing pages and apps to offer a secure environment to its users.
个人数据类别：
接收者：
合法利益
- To manage corporate reorganization activities.
个人数据类别：
接收者：
合法利益
- To interact (i.e., respond to messages or comments, generate reactions, share content, etc.) with users of Grifols' profiles on social networks, which would involve the communication of certain data (i.e., IP address and browsing history data) to the providers of these social networks.
个人数据类别：
接收者：
合法利益
- To send scientific, educational and commercial information about Grifols' group products, services and activities, by any means, including electronic ones, if a contractual relationship with the data subject does not exist. 如第6节所规定，数据主体可以行使其反对权，并撤回其同意为直接营销目的处理其数据。
- To manage and control the registration, participation and attendance of data subjects to symposiums, conferences, webinars, training sessions, scientific awards or similar events, in person or online, organized by Grifols or third parties.
个人数据类别：
接收者：
同意
- To create profiles of data subjects based on their preferences and personal interests; this information is provided by the data subjects, obtained from the third-party sources detailed in Section 5 and from analysing their behaviour (through cookies or similar technologies) when receiving or interacting with communications from Grifols or when browsing the internet. 基立福将使用这些个人资料发送符合数据主体偏好、兴趣和行为的通讯，但将不会根据个人资料自动做出决策。如第 6 节中说明，数据主体可行使其反对和撤销通过处理个人数据创建个人资料用于直接营销目的的同意书。有时，数据主体的个人资料将以汇总方式编制，这样基立福将不能以任何方式了解其身份，在这些情况下将会使用汇总信息分析数据主体细分的行为。
个人数据类别：
接收者：
同意
- To customize certain features of websites, landing pages and apps based on the data subjects' browsing preferences and analyse their browsing behaviour with the aim to improve the services offered through these platforms. 如果适用，可在相关网页、登陆页面或应用程序的Cookies政策中找到。
个人数据类别：
接收者：
同意
- To publish the transfers of value (compensation) made to data subjects, to comply with the Grifols' group policy, as well as with the guidelines and regulations issued by the different associations of the pharmaceutical industry to ensure greater transparency in the interactions between the different market players.
个人数据类别：
接收者：
同意
- To use the data subjects' personal data (including their image, voice and any other identifying feature) in the terms regulated in the authorization document for the recording and use of images or other identifying features or in any other communication of similar characteristics, as well as for evidencing the consent of the data subjects.
个人数据类别：
接收者：
同意
- To share the personal data with distributors of companies of the Grifols' group for the latter to use the personal data to evaluate potential business opportunities and collaborations.
个人数据类别：
接收者：
同意
- To respond to medical and technical (non-commercial) requests for information about products manufactured or distributed by Grifols.
个人数据类别：
接收者：
法律义务
- To publish the transfers of value (compensation) made to the data subjects to ensure greater transparency in the interactions held among the distinct market players, as further detailed in Section 7.
个人数据类别：
接收者：
法律义务
- To comply with certain regulatory obligations resulting from interactions with data subjects.
个人数据类别：
接收者：
法律义务
- To execute and maintain the existing contractual relationship between Grifols and the data subjects, including the communication of the personal data and the use of the image, voice or other identifying features of the data subjects necessary to accomplish the contractual purposes.
个人数据类别：
接收者：
合同的执行
- To manage travel and events
个人数据类别：
接收者：
金融实体。
合同的执行
合法利益
| 目的 | 个人数据的类别和接收方 | 合法依据 |
|---|---|---|
|
- To contact data subjects by any means, including electronic ones, to evaluate potential business opportunities and collaborations, and to develop, control and manage current and future relationships. 与数据主体联系的原因可能包括但不限于： - Scheduling appointments (online or in-person), - Evaluating their participation as speakers or members in advisory boards, symposiums, conferences, webinars, training sessions, scientific awards, clinical studies or similar events organized by Grifols or by third parties (online or in-person), and in drafting scientific publications, - Sending surveys or similar, and - Any other activities that may contribute to evaluating potential business opportunities. - To assess and, if applicable, to respond to any requests for information or suggestions. - To develop and maintain the relationship with personnel of the organizations with whom Grifols has a contractual relationship, including the management of training sessions. |
个人数据类别：
接收者：
|
合法利益 |
|
- To send scientific, educational and commercial information about Grifols’ group products, services, and activities, by any means, including electronic ones, when there is a contractual relationship with the data subject (e.g. direct marketing). - To send scientific and educational information, which is not related to Grifols’ group products, services and activities, to increase the knowledge in the scientific community. |
个人数据类别：
接收者：
|
合法利益 |
|
- To carry out anticorruption compliance checks. |
个人数据类别：
接收者：
|
合法利益 |
|
- To carry out maintenance tasks in websites, landing pages and apps to offer a secure environment to its users. |
个人数据类别：
接收者：
|
合法利益 |
|
- To manage corporate reorganization activities. |
个人数据类别：
接收者：
|
合法利益 |
|
- To interact (i.e., respond to messages or comments, generate reactions, share content, etc.) with users of Grifols' profiles on social networks, which would involve the communication of certain data (i.e., IP address and browsing history data) to the providers of these social networks. |
个人数据类别：
接收者：
|
合法利益 |
|
- To send scientific, educational and commercial information about Grifols' group products, services and activities, by any means, including electronic ones, if a contractual relationship with the data subject does not exist. 如第6节所规定，数据主体可以行使其反对权，并撤回其同意为直接营销目的处理其数据。 - To manage and control the registration, participation and attendance of data subjects to symposiums, conferences, webinars, training sessions, scientific awards or similar events, in person or online, organized by Grifols or third parties. |
个人数据类别：
接收者：
|
同意 |
|
- To create profiles of data subjects based on their preferences and personal interests; this information is provided by the data subjects, obtained from the third-party sources detailed in Section 5 and from analysing their behaviour (through cookies or similar technologies) when receiving or interacting with communications from Grifols or when browsing the internet. 基立福将使用这些个人资料发送符合数据主体偏好、兴趣和行为的通讯，但将不会根据个人资料自动做出决策。如第 6 节中说明，数据主体可行使其反对和撤销通过处理个人数据创建个人资料用于直接营销目的的同意书。有时，数据主体的个人资料将以汇总方式编制，这样基立福将不能以任何方式了解其身份，在这些情况下将会使用汇总信息分析数据主体细分的行为。 |
个人数据类别：
接收者：
|
同意 |
|
- To customize certain features of websites, landing pages and apps based on the data subjects' browsing preferences and analyse their browsing behaviour with the aim to improve the services offered through these platforms. 如果适用，可在相关网页、登陆页面或应用程序的Cookies政策中找到。 |
个人数据类别：
接收者：
|
同意 |
|
- To publish the transfers of value (compensation) made to data subjects, to comply with the Grifols' group policy, as well as with the guidelines and regulations issued by the different associations of the pharmaceutical industry to ensure greater transparency in the interactions between the different market players. |
个人数据类别：
接收者：
|
同意 |
|
- To use the data subjects' personal data (including their image, voice and any other identifying feature) in the terms regulated in the authorization document for the recording and use of images or other identifying features or in any other communication of similar characteristics, as well as for evidencing the consent of the data subjects. |
个人数据类别：
接收者：
|
同意 |
|
- To share the personal data with distributors of companies of the Grifols' group for the latter to use the personal data to evaluate potential business opportunities and collaborations. |
个人数据类别：
接收者：
|
同意 |
|
- To respond to medical and technical (non-commercial) requests for information about products manufactured or distributed by Grifols. |
个人数据类别：
接收者：
|
法律义务 |
|
- To publish the transfers of value (compensation) made to the data subjects to ensure greater transparency in the interactions held among the distinct market players, as further detailed in Section 7. |
个人数据类别：
接收者：
|
法律义务 |
|
- To comply with certain regulatory obligations resulting from interactions with data subjects. |
个人数据类别：
接收者：
|
法律义务 |
|
- To execute and maintain the existing contractual relationship between Grifols and the data subjects, including the communication of the personal data and the use of the image, voice or other identifying features of the data subjects necessary to accomplish the contractual purposes. |
个人数据类别：
接收者：
|
合同的执行 |
|
- To manage travel and events |
个人数据类别：
接收者：
金融实体。 |
合同的执行 |
3.1. 有关处理个人数据的合法依据的补充信息
上表按用途显示了处理个人数据的适用法律依据。在本节中，您可以找到有关处理合法性的其他详细信息：
在任何情况下，数据主体均可通过向privacy@grifols.com提出请求，要求提供有关合法权益的进一步消息，或行使其反对基于合法权益处理其个人数据的权利。
3.2，个人数据接收方
上表显示了基立福可能按目的与之分享个人数据的接收方类别。本节包括有关这些接收者的其他信息（如适用）：
基立福网站包含可通过社交网络的徽标或名称识别的社交网络插件，以便用户在这些平台上访问基立福存储的个人资料。点击这些按钮，用户的个人数据（包括 IP 地址和浏览数据）将被传输给上述社交网络的提供商。对于社交网络提供商可能对这些个人数据作出的任何进一步处理行为，基立福将不承担任何责任。有关这些社交网络提供商收集数据与后续处理和使用的目的和范围，以及相关权利和配置隐私设置的可能性，可在这些公司的数据保护信息中进行查阅。
基立福尽力仅将个人数据传输至提供足够数据保护水平的国家/地区。如果在未提供上述保护水平的国家/地区处理个人数据，基立福和/或提供者（视情况而定）将在必要时根据适用的数据保护法规采取适当的保障措施（例如在 GDPR 适用条件下包括 2021年 6 月 4 日 Commission Implementing Decision (EU) 2021/914 中包含的标准合同条款）来进行此类国际数据传输。有关适用于各项国际数据传输的适当保障措施的具体信息，可通过 基立福网站 privacy@grifols.com获取。
基立福仅在获得数据主体授权或适用法律要求下才会与其他第三方分享个人数据。
4，保留期限
基立福将在完成收集目的所严格需要的时间内保留个人数据，或者在适用的情况下，保留到任何可能产生的责任的时效结束，以及在遵守任何适用的法律义务所需的期限内。
5，个人数据来源
如果数据主体不直接向基立福提供其个人数据，基立福可以从活动组织者的数据库和公共来源——如医疗保健行业网站和出版物、专业社交网络或社会倾听工具（即旨在识别和评估市场对特定品牌、产品、公司、主题或问题的看法的工具）——获得个人数据。
如果数据主体为执行和维护合同关系而提供第三方个人数据，则应提供本隐私政策副本，提前告知上述第三方有关其个人数据的处理情况。
6，数据保护权利
以下数据保护权利在GDPR规定下适用。基立福承诺尊重依照各国家/地区适用的数据保护法规可能适用的其他数据保护权利。
访问
您可以要求确认是否正在处理您的个人数据，如果确实如此，您可以获取访问基立福文件中包含的个人数据的权限。
纠正
如果您的个人数据不准确，您可以要求纠正。
删除
您可以要求删除个人数据。
反对
您可以要求在特定情况下不处理您的个人数据。
可移植性
您可以要求以电子文件的形式接收您向基立福提供的个人数据，并有权将这些数据传输给其他当事方。
限制处理
在以下情况下，您可以要求对如何处理您的个人数据进行限制：
撤回同意
您可以撤回同意，而不影响在撤回之前基于同意的合法处理。
| 权利 | 内容 |
|---|---|
|
访问 |
您可以要求确认是否正在处理您的个人数据，如果确实如此，您可以获取访问基立福文件中包含的个人数据的权限。 |
|
纠正 |
如果您的个人数据不准确，您可以要求纠正。 |
|
删除 |
您可以要求删除个人数据。 |
|
反对 |
您可以要求在特定情况下不处理您的个人数据。 |
|
可移植性 |
您可以要求以电子文件的形式接收您向基立福提供的个人数据，并有权将这些数据传输给其他当事方。 |
|
限制处理 |
在以下情况下，您可以要求对如何处理您的个人数据进行限制：
|
|
撤回同意 |
您可以撤回同意，而不影响在撤回之前基于同意的合法处理。 |
您可在适当情况下行使您的数据保护权利，例如，通过 privacy@grifols.com向基立福 发送主题为“HCP 和商业合同交互”的书面通信。为此，基立福可能会要求您提供更多的必要信息和文件，以确定您的身份。
对于美国居民，请联系隐私办公室：US-PrivacyRights@Grifols.com。
此外，您可以向数据保护机构提出投诉，包括您的住所、工作地点或涉嫌侵权行为发生地的数据保护机构。
7，特定规定
上次更新： 2023年3月
Vacuum gauge
A vacuum gauge is a device used to measure the pressure and vacuum in specific spaces.
gmp
Good Manufacturing Practices.
Agglutination technique
Technique for pretransfusion tests based on the Ag-Ab reaction (antigens-antibodies), causing a given agglutination, which can then be observed to determine the blood type. This technique can be performed in a tube, a gel column or on microplates.
ABO blood group system
System used to group human blood into different types depending on the presence or absence of certain markers on the surface of the red blood cells. The four main blood types are A, B, O and AB.
Albumin
Plasma protein fraction commonly used as a macromolecular medium in the incubation of laboratory tests, reducing what is known as the "zeta-potential". As a hemoderivative, it is used as a plasma volume expander and for protein replacement in some cases.
Antibody
Protein synthesized by the body in response to the introduction of an antigen.
Angiography
Exploratory radiological technique in which a contrast fluid is injected into the vascular system to render the blood opaque and thus enable observation of the internal state of blood vessels.
Blood agglutination
Antigens have the capacity to stimulate the immune system, triggering a response in the form of antibodies. This reaction determines compatibility between different blood groups. First, the antigen binds to the antibody. The antibodies then react to the appearance of contrary antigens, causing the red blood cells to form clumps or agglutinate.
Angiogram
X-ray or image of the blood vessels and flow of blood within the body.
Anticoagulant
Substance that prevents or reduces blood coagulation.
Antiglobulin
Antibody that reacts with the plasma globulins.
DNA
Deoxyribonucleic acid: a nucleic acid that contains the genetic instructions used in the development and functioning of all living organisms and some viruses. It is also responsible for hereditary transmission.
Asepsis
Absence of pathogenic micro-organisms.
Antiserum
Serum or reagent that contains specific antibodies (immunoglobulins) against one or more antigens.
Antigen
Foreign body that enters the organism and prompts an immune response.
Artificial vision
This is the process of obtaining, describing and interpreting information from images.
Urea
Crystalline or colorless organic substance found primarily in the blood and urine. It is formed in the liver as an end product of metabolism and excreted in urine and sweat.
Screening
Refers to a preliminary test or study.
Serum
Liquid portion of coagulated blood.
Sulfonamide
Chemical substance derived from colorants, used in the treatment of several infectious diseases.
serology
Biological study of blood serum. Study of the antigen-antibody complexes in serum, to detect the presence of certain diseases.
spectrometer
Device used to study the composition of the light emitted by a source.
Spectrophotometry
Measurement of the relative light intensity of simple emissions.
spectroscope
Optical instrument used to record the spectrum of a given emission.
Spectrophotometer
Instrument combining the properties of a spectrometer and a photometer, used to determine the intensity of any range of wavelengths absorbed by a solution.
spectroscopy
Branch of physics that studies spectrums.
spectrum
Distribution of the intensity of radiation as a function of a given magnitude, such as wavelength, energy or temperature.
Residual transfusion risk
Probability (mathematical or statistical) that the transfusion of a blood component might transmit an infectious agent (virus) after performing tests using direct or indirect detection methods, antigen methods or based on immune response elements.
Rh factor
The Rhesus (Rh) factor is an inherited protein found on the surface of red blood cells. A person is Rh+ if they possess this protein, and Rh– if they don't.
RNA
Ribonucleic acid. This is a nucleic acid formed from a chain of ribonucleotides, present in eukaryotic and prokaryotic cells, which participates in the intermediate stages of protein synthesis, following the program recorded in the genetic code.
Rheostat
Instrument to vary the resistance of an electrical circuit.
Phenotype
The observable characteristics or traits of an organism that are produced by the interaction of the genotype and the environment.
Photometer
Device that measures light intensity.
Pipetting technique
Pipetting involves using a pipette to draw up a given quantity of liquid. The technique allows liquids to be dispensed quickly and accurately.
Photometry
Measurement of light intensity and of corresponding amplitudes.
Plasma
Liquid portion of uncoagulated blood, yellow in color, obtained after separating out the cellular elements. Contains water, electrolytes, proteins, fats and proteins.
Pyrogenic
Fever-inducing.
Lyophilized plasma
Plasma that has undergone lyophilization to extend its shelf life.
Platelets
Platelets, also referred to as thrombocytes, are tiny fragments of cytoplasm from very large cells called megakaryocytes. Platelets are formed from these large cells in the bone marrow and are released into the bloodstream, where they are essential for enabling normal blood coagulation.
Plasmapheresis
Technique by which whole blood is extracted from a donor and processed to separate the white blood cells, red blood cells and platelets from the plasma. The blood cells are then returned to the donor, minus the plasma, which the body can replace rapidly.
Nomogram
Graphic representation that enables rapid approximate numerical calculation (nomography).
nat
Nucleic Acid Testing: RNA and DNA tests to detect infectious viral agents based on the amplification of nucleic acid fragments.
Nephritis
Inflammation of the kidneys.
Microplate technique
Technique to observe agglutination, using plates with multiple wells which are used as small test tubes. This technique enables automation of the process and is used for large series of samples.
Microcentrifuge
Specialized centrifuge used in a clinical laboratory for capillary tubes.
Lyophilizer
A lyophilizer is a device used to perform lyophilization.
Lyophilization
Conservation method that consists of conducting a sublimation process by dehydrating a substance through rapid freezing, and transforming the ice humidity into vapor by means of the application of vacuum.
Immunoglobulin
Plasma protein associated with immune processes. All antibodies are immunoglobulins, but not all immunoglobulins perform the antibody function.
Hematocrit
The volumetric proportion of red blood cells in the blood. This value is obtained by performing a blood test in a laboratory. The normal hematocrit values depend on the references selected by the laboratory. In general, average values are between 41% and 51% for men, and between 36% and 45% for women.
Hemolysis
The process of decomposition of red blood cells.
Hemostasis
Hemostasis is the interruption of hemorrhage either spontaneously or by physical means, such as manual compression or tourniquet, or chemical means, such as the use of drugs.
Inoculate
Introduce into an organism a substance that contains the germ of a disease.
Incubator
Device that regulates the optimum temperature, humidity and ventilation to preserve and grow microbiological and cell cultures in a laboratory. Essential for much experimental work in biology, and in pharmaceutical, hematological and biochemical studies, among others.
Hemogram
Study that makes it possible to identify the composition of blood and which is used as a clinical analysis tool.
Genotype
An individual's set of genes.
Heparin
Heparin is a natural substance in the blood which interferes with the blood clotting process. It acts on a substance called thrombin, which plays an important role in the formation of blood clots.
Heparinization
Treatment with heparin to prevent blood coagulation.
Globulin
Particular class of protein, to which antibodies belong.
Genotyping
Genotyping is the process by which differences in the genetic makeup or genotype of an individual are identified by analysis of their individual DNA sequence. This can be done by comparing the genotype with another individual's sequence or with a reference sequence.
Flebula
Glass tube with vacuum, used to obtain blood samples for clinical analysis under aseptic conditions.
ELISA technique
Enzyme-linked immunosorbent assay: immunological technique where the reaction between antigen and antibody is detected by spectrophotometric determination of the action of an enzyme that is linked to the antigen or antibody. It is cheaper and simpler than radioimmunoassay, with similar effectiveness. It is also called enzyme immunoanalysis or enzyme immunoassay.
edta
Ethylenediaminetetraacetic acid: an anticoagulant used in hematology.
glp
Good Laboratory Practice.
Red blood cell
Red blood cells, also referred to as erythrocytes, are the most common type of blood cell, and are responsible for transporting oxygen from the lungs to the different tissues, organs and systems of the body, a task they perform thanks to a protein called hemoglobin.
Centrifuge
Laboratory instrument that applies centrifugal force to accelerate the separation of solid particles suspended in a liquid, based on their density. It is used, for example, to separate plasma and blood serum from blood cell components during analysis for blood testing.
Sodium citrate
Sodium citrate is the sodium salt of citric acid. It is used as an anticoagulant in tubes used to extract blood in some laboratory tests that measure blood clotting time, including activated partial thromboplastin time and prothrombin time. The concentration of sodium citrate used as an anticoagulant is an important pre-analytic variable because blood plasma clotting time may vary as the quantity of citrate present affects the concentration of calcium used in these tests.
Coombs test
Diagnostic test that can detect the presence of antibodies in the serum that react with antigens on the surface of the red blood cells. Used to diagnose blood disorders in which the patient produces antibodies against their own red blood cells and platelets. Also used to determine blood type.
Gel column agglutination technique
Agglutination technique to determine blood groups and for transfusion compatibility studies, which uses gel as a reagent. This gel sits in columns on cards of 6 to 8 wells.
Amino acid
Organic chemical substance that is the basic component of proteins. Amino acid solutions are one of the components of parenteral nutrition mixtures and must be administered in combination with appropriate quantities of energy preparations for infusion (solutions of carbohydrates and/or lipid emulsions).
Cross contamination
Microorganism contagion from patient to health professional, from health professional to patient, or from patient to patient. Occurs when microorganisms are transferred to nearby equipment, clothing or furniture.
Chemotherapy
Treatment with drugs to interrupt the formation of cancer cells, whether by destroying them or by preventing them from multiplying. Chemotherapy is administered orally, by injection, by infusion or onto the skin, depending on the type of cancer and the stage of the disease. It is administered alone or combined with other treatments such as surgery, radiation therapy or biological therapy.
Carousel
Revolving cabinets. The contents of the system are transported by a structure that rotates either vertically or at floor level. Both systems facilitate the product selection process by transporting the items to the operatives. Carousels optimize storage space and selection time.
Blister pack
Package consisting of two layers, normally plastic and metal (aluminum), heat-set to form ampoule-shaped cavities which can contain individual doses of the product. This form of presentation facilitates identification of the tablet and protects individual tablets from external agents.
Autoclave
Device that uses water vapor at high pressure and high temperature to destroy microorganisms, in order to achieve asepsis. Used to sterilize non-disposable hospital and surgical material, in the manufacture of parenteral solutions, and with other products that need to be sterilized and can withstand this physical process.
Enteral
Introduced into the organism via the gastrointestinal tract, whether orally or via the nasogastric route.
FDA
Acronym of Food and Drug Administration. The government agency of the US Department of Health and Human Services that is responsible for regulating food, drugs, biological products and blood-derived products.
Industrial filling
In the pharmaceutical industry, the standardized process of aseptic filling of pharmaceutical products, parenteral solutions or plasma-derived products.
Cryoprecipitate
The fraction of plasma proteins that remains insoluble when the fresh frozen plasma is thawed under appropriate temperature conditions. Contains factor VIII (coagulant, 80–120 U), von Willebrand factor VIII, fibrinogen (around 250 mg), factor IX, factor XIII and fibronectin.
Cytostatic
Refers to a drug or therapy used to treat cancer by inhibiting cell proliferation, such as in anti-tumor treatments.
Hemoderivative
Substance or product derived from blood or plasma. Pharmaceutical preparations whose active principle comes from the blood of healthy donors via an appropriate fractionation and purification process, and which cannot be obtained using chemical or biological synthesis methods.
Fractionation
Separation of therapeutic proteins from plasma using physical and chemical processes.
Fluid therapy
Therapy consisting in the parenteral administration of liquids and electrolytes, in order to maintain or reestablish homeostasis in the patient's body. The main objectives are to maintain adequate hydration and tissue perfusion with electrolytic equilibrium.
Gene therapy
Any treatment consisting in introducing specific genes into the patient's cells to combat certain diseases.
Injection
Action and effect of introducing a gas, liquid or drug solution into a blood vessel, body cavity or tissue under pressure using a syringe or suitable instrument.
Intravenous infusion
Technique of introducing a liquid into the bloodstream in order to hydrate the patient or administer a drug.
Hemophilia
Hereditary disease, transmitted by autosomal recessive inheritance – the presence of two copies of an abnormal gene – and sex-linked, in which there is a deficit in the production of various plasma factors that are essential to correct blood coagulation: factor VIII (hemophilia A) and factor IX (hemophilia B).
Intravenous therapy
Any treatment consisting in the administration and monitoring of liquids, medicines or both into the general bloodstream by piercing a vein. The aim is to ensure maximum therapeutic impact in comparison to oral therapy, which tends to take longer to act and be less effective.
Intravenous mixture (IVM)
Preparation obtained by adding medicines for intravenous use to containers of solutions for fluid therapy. Can be prepared either by reconstitution (by dissolving a solid medicine in a solvent) or by mixing preparations in an existing watery solution.
Laser
Acronym of Light Amplification by Stimulated Emission of Radiation.
Nosocomial disease
Refers to disease or infection acquired in a hospital or health facility.
Oncology
Branch of medicine that manages the treatment of anomalous cell proliferation (tumor) using cytostatic drugs, radiation therapy, immunosuppression or surgery of cancerous tumors.
Clinical nutrition
Medical discipline that improves the quality of life of patients with a range of pathologies by providing specific nutritional therapy to patients who find it difficult or impossible to ingest food, or provided as a complement to food.
Lipid
Name given to fatty materials and analogous triglycerides. Lipid solutions or emulsions are mixtures created by dissolving lipids in a liquid for intravenous use.
Ranitidine
Drug that inhibits the secretion of gastric acid, used in the treatment of stomach ulcers.
Sensor
In medicine, device that responds to a stimulus, such as heat, light or pressure, and produces a signal that can be measured or interpreted.
Polypropylene
Thermoplastic obtained by polymerizing propylene, a gaseous by-product of petroleum refining. It is an inert material that is suitable for the preparation of some intravenous mixtures that are incompatible with other plastics.
Perfusion
In medicine, the action of introducing a liquid such as blood, serum or antibiotic into the body intravenously in a slow, sustained manner.
Perfusion System
Device used to administer intravenous liquids, consisting of a plastic tube, a regulating clamp, a connection and a syringe.
Parenteral
Introduced into the organism by a pathway other than the digestive tract, such as intravenous, subcutaneous, intramuscular or intradermal. Parenteral solutions are typically constituted with saline solution, gluconate or a combination of these, and may contain amino acids, electrolytes, vitamins or drugs, or they may be lipid emulsions of various products that are not water-soluble.
Sterile
Free of pathogenic germs. Aseptic.
Taurine
Organic compound belonging to the amino acid group, present in some foods of animal origin and also occurring naturally in some of our body tissues. Intervenes in the formation of bile and many other functions. Its name derives from the Latin taurus (meaning bull) because it was first isolated in the bile of a bull in 1827 by the German scientists Friedrich Tiedemann and Leopold Gmelin.
Intravenous
Existing, occurring or administered in one or more veins.
Vial
Small flask containing injectable medicine, from which doses of the medicine are extracted as required.
Clean zone
Room that has been specially designed to ensure low levels of contamination. The cleanliness and environmental parameters such as temperature, humidity, light levels, pressure and flow of particles in the air are strictly controlled to comply with specified parameters.
Jacketed vessel
Tank designed to control the temperature of its contents through the use of an external cavity ("jacket") through which fluid is circulated, permitting heat exchange to produce uniform cooling or heating of the contents.
Diaphragm pump
A diaphragm pump is a type of positive displacement pump, generally alternating, in which pressure is increased through the action of elastic walls – diaphragms or membranes – that vary the volume in the chamber, alternately increasing and reducing it. Retention valves control the movement of fluid from the lower pressure to the higher pressure zone.
Photocolorimeter
Type of colorimeter. Instrument used in chemistry to determine concentration of substances dissolved in liquids or solids so long as they are transparent to visible, ultraviolet or infrared light, measuring and comparing their colors.
Blood typing
Analysis to determine ABO blood group and Rh type. It is always used before transfusion of blood or blood components and when blood is donated. It is also used on pregnant women to determine the risk of Rh incompatibility between mother and fetus.
Capillary tube
Fluid conduit with an interior diameter similar to that of a hair. Can be made from a variety of materials: glass, copper, metal alloys, etc., depending on its use or application.
Antiseptic
Substance that destroys or inhibits the growth of microorganisms.
